Embecta Corp. (EMBC) Faces Securities Class Action for Allegedly Concealing Competitive Threats to Pen Needle Business -- HBSS

Hagens Berman announced a securities class action lawsuit against Embecta, alleging the company concealed competitive threats to its pen needle business. The complaint cites a discrepancy between prior assurances of business stability and the subsequent Q2 report, where adjusted EPS fell to $0.27 and full-year guidance was slashed by roughly 43% to $1.55-$1.75. Investors who purchased shares between Nov. 25, 2025, and May 4, 2026, are encouraged to contact the firm before the Aug.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.